Ravi Murthy, M.D., M.M.M., F.A.C.P., F.S.I.R.

Peer-Reviewed Articles

1. Pal K, Kuban JD, Murthy R, Odisio BC, Metwalli ZA. A sticky situation: Glue migration during hepatic vein embolization. Semin Intervent Radiol 40(3):254-257, 2023. e-Pub 2023. PMID: 37484445.
2. Babiker H, Borazanci E, Subbiah V, Agarwala S, Algazi A, Schachter J, Lotem M, Maurice-Dror C, Hendler D, Rahimian S, Minderman H, Haymaker C, Mahadevan D, Bernatchez C, Murthy R, Hultsch R, Kaplan N, Woodhead G, Hennemeyer C, Chunduru S, Anderson PM, Diab A, Puzanov I. Tilsotolimod exploits the TLR9 pathway to promote antigen presentation and Type 1 IFN signaling in solid tumors: A Multicenter International Phase I/II trial (ILLUMINATE-101). Clin Cancer Res 28(23):5079-5087, 2022. e-Pub 2022. PMID: 35917516.
3. Habibollahi P, Odisio BC, Gurusamy V, Kuban JD, Avritscher R, Abdelsalam ME, Chasen BA, Murthy R, Mahvash A. Temporary reversal of hepatoenteric collaterals during 90Y radioembolization planning and administration. Curr Oncol 29(12):9582-9592, 2022. e-Pub 2022. PMID: 36547167.
4. Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
5. Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW, Safa H, James M, Andtbacka RHI, Johnson DB, Shaheen M, Davies MA, Rahimian S, Chunduru SK, Milton DR, Tetzlaff MT, Overwijk WW, Hwu P, Gabrail N, Agrawal S, Doolittle G, Puzanov I, Markowitz J, Bernatchez C, Diab A. Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma. Cancer Discov 11(8):1996-2013, 2021. e-Pub 2021. PMID: 33707233.
6. Muñoz NM, Williams M, Dixon K, Dupuis C, McWatters A, Avritscher R, Manrique SZ, McHugh K, Murthy R, Tam A, Naing A, Patel SP, Leach D, Hartgerink JD, Young S, Prakash P, Hwu P, Sheth RA. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer 9(2):e001800, 2021. PMID: 33589526.
7. Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, Shepard DR, Helgason T, Masters T, Hong DS, Piha-Paul SA, Karp DD, Klang M, Huang SY, Sakamuri D, Raina A, Torrisi J, Solomon SB, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom JL, Korn RL, Zhang L, Saha S, Leontovich AA, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder MM. Intratumoral injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors. Clin Cancer Res 27(1):96-106, 2021. e-Pub 2020. PMID: 33046513.
8. Murthy R, Rachakonda V, Bassuner J. Refractory biliary catheter leak corrected by a hybrid closed loop catheter-pump system. Case Rep Radiol 2021(Article ID 6677500):6677500, 2021. e-Pub 2021. PMID: 33763277.
9. Sheth RA, Murthy R, Hong DS, Patel S, Overman MJ, Diab A, Hwu P, Tam A. Assessment of image-guided intratumoral delivery of immunotherapeutics in patients with cancer. JAMA Netw Open 3(7):e207911, 2020. e-Pub 2020. PMID: 32725245.
10. Tapia C, Aung PP, Roy-Chowdhuri S, Xu M, Ouyang F, Alshawa A, Hajjar J, Singh G, Yang V, Castillo L, Le H, Murthy R, Stephen B, Hess KR, Wistuba I, Naing A. Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer 8(1), 2020. PMID: 32303619.
11. Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC. Survival outcomes for yttrium-90 transarterial radioembolization with and without sorafenib for unresectable hepatocellular carcinoma patients. J Hepatocell Carcinoma 7:117-131, 2020. e-Pub 2020. PMID: 32984089.
12. Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R| Tam A, Andreopoulou E, Gong Y, Murthy R, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W. SET ER/PR - A robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer 5:16, 2019. e-Pub 2019. PMID: 31231679.
13. Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN. Preoperative drainage for perihilar cholangiocarcinoma. Lancet Gastroenterol Hepatol 4(1):10-11, 2019. e-Pub 2018. PMID: 30527574.
14. Subbiah V, Murthy R, Hong DS, Prins RM, Hosing C, Hendricks K, Kolli D, Noffsinger L, Brown R, McGuire M, Fu S, Piha-Paul S, Naing A, Conley AP, Benjamin RS, Kaur I, Bosch ML. Cytokines produced by dendritic cells administered intratumorally correlate with clinical outcome in patients with diverse cancers. Clin Cancer Res 24(16):3845-3856, 2018. e-Pub 2018. PMID: 30018119.
15. Murthy R, Borges VF, Conlin A, Chaves J, Chamberlain M, Gray T, Vo A, Hamilton E. Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: A non-randomised, open-label, phase 1b study. Lancet Oncol 19(7):880-888, 2018. e-Pub 2018. PMID: 29804905.
16. Odisio BC, Cox VL, Faria SC, Yamashita S, Shi X, Ensor J, Jones AK, Mahvash A, Gupta S, Tam AL, Vauthey JN, Murthy R. Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis. Eur Radiol 27(11):4837-4845, 2017. e-Pub 2017. PMID: 28484824.
17. Abdelsalam ME, Mahvash A, Madoff DC, Odisio BC, Kuban JD, Avritscher R, Murthy R. Radioembolization in colorectal metastases: A review. Digestive Disease Interventions 01(03):208-217, 2017.
18. Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple renal artery pseudoaneurysms in patients undergoing renal artery embolization following partial nephrectomy: Correlation with renal nephrometry scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2016. PMID: 27681271.
19. Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a self-expanding tract sealant device in the reduction of pneumothorax and chest tube placement rates after percutaneous lung biopsy: A matched controlled study using propensity score analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2016. PMID: 27826786.
20. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural history of T1N0M0 hepatocellular carcinoma: Large-scale study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
21. Heilmann AM, Subbiah V, Wang K, Sun JX, Elvin JA, Chmielecki J, Sherman SI, Murthy R, Busaidy NL, Subbiah I, Yelensky R, Nangia C, Vergilio JA, Khan SA, Erlich RL, Lipson D, Ross JS, Miller VA, Shah MH, Ali SM, Stephens PJ. Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Oncology. e-Pub 2016. PMID: 27207748.
22. Maiti A, Brown RE, Corn PG, Murthy R, Ganeshan DM, Tsimberidou AM, Subbiah V. Anti-tumor response to combined anti-angiogenic and cytotoxic chemotherapy in recurrent metastatic chromophobe renal cell carcinoma: Response signatures and proteomic correlates. Clin Genitourin Cancer 14(2):e187-93, 2016. e-Pub 2015. PMID: 26684814.
23. Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO. Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatocell Carcinoma 3:1-7, 2016. e-Pub 2016. PMID: 27574586.
24. Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma 3:55-61, 2016. e-Pub 2016. PMID: 27785450.
25. Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S. The effect of needle gauge on the risk of pneumothorax and chest tube placement after percutaneous computed tomographic (CT)-guided lung biopsy. Cardiovasc Intervent Radiol 38(6):1595-602, 2015. e-Pub 2015. PMID: 25920917.
26. Steele JR, Jones AK, Ninan EP, Clarke RK, Odisio BC, Avritscher R, Murthy R, Mahvash A. Why bundled payments could drive innovation: An example from interventional oncology. J Oncol Pract. e-Pub 2015. PMID: 25604596.
27. Roberts NJ, Zhang L, Janku F, Collins A, Bai RY, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, Khanna KV, Murthy R, Benjamin RS, Helgason T, Szvalb AD, Bird JE, Roy-Chowdhuri S, Zhang HH, Qiao Y, Karim B, McDaniel J, Elpiner A, Sahora A, Lachowicz J, Phillips B, Turner A, Klein MK, Post G, Diaz LA, Riggins GJ, Papadopoulos N, Kinzler KW, Vogelstein B, Bettegowda C, Huso DL, Varterasian M, Saha S, Zhou S. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6(249):249ra111, 2014. PMID: 25122639.
28. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?. World J Radiol 5(6):241-7, 2013. PMID: 23807902.
29. May BJ, Murthy R, Madoff DC. What's new in transarterial therapies for hepatocellular carcinoma?. Gastrointest Cancer Res 5(3 Supplement 1):S14-S19, 2012. PMID: 22876334.
30. Mahvash A, Zaer N, Shaw C, Chasen B, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-280, 2012. PMID: 22264555.
31. Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: Proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 23(2):153-163, 2012. PMID: 22264550.
32. Avritscher R, Wright KC, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett RL, Murthy R, Wallace MJ, Madoff DC. Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: A study in swine. J Vasc Interv Radiol 22(9):1329-1334, 2011. e-Pub 2011. PMID: 21802316.
33. Subbiah V, Murthy R, Anderson PM. [90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29(11):e292-4, 2011. e-Pub 2011. PMID: 21245431.
34. Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A, Technology Assessment Committee, Interventional Oncology Task Force of the Society of Interventional Radiology. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22(3):265-278, 2011. PMID: 21353979.
35. Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: Response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, 2010. e-Pub 2009. PMID: 19935383.
36. Gupta S, Sultenfuss M, Romaguera JE, Ensor J, Krishnamurthy S, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. CT-guided percutaneous lung biopsies in patients with hematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol 28(2):75-81, 2010. e-Pub 2009. PMID: 19728397.
37. Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, Murthy R, Hicks ME, Wallace MJ. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer 116(8):1974-1980, 2010. e-Pub 2010. PMID: 20151422.
38. Gayed I, Wahba H, Nunez R, Murthy R. Effect of Y-90 SirSpheres therapy for multiple liver metastases in a variety of tumors. J Cancer Sci Ther 2(2):043-046, 2010.
39. Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol 32(6):574-581, 2009. e-Pub 2009. PMID: 19636238.
40. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation. Transcatheter therapy for hepatic malignancy: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S425-S434, 2009. PMID: 19560030.
41. Briere TM, Beddar S, Balter P, Murthy R, Gupta S, Nelson C, Starkschall G, Gillin MT, Krishnan S. Respiratory gating with EPID-based verification: The MDACC experience. Phys Med Biol 54(11):3379-91, 2009. e-Pub 2009. PMID: 19436104.
42. Liu DM, Kennedy A, Turner D, Rose SC, Kee ST, Whiting S, Murthy R, Nutting C, Heran M, Lewandowski R, Knight J, Gulec S, Salem R. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol 31(6):200-215, 2009. PMID: 19346815.
43. Jakobs TF, Hoffmann RT, Schrader A, Stemmler HJ, Trumm C, Lubienski A, Murthy R, Helmberger TK, Reiser MF. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol 32(1):38-46, 2009. e-Pub 2008. PMID: 18575933.
44. Fong Y, Hapreet W, Leung T, Warner R, Pennington K, Kalayoglu M, Hall M, Rose S, Smith R, Liu D, Murthy R, Kennedy A, Nutting C, Salem R, Gulec S. Integration of radiomicrosphere therapy into the contemporary management strategies for primary and metastatic liver cancer: Oncology expert opinions and recommendations. J Interv Onc 2:46-58, 2009.
45. Jakobs TF, Saleem S, Atassi B, Reda E, Lewandowski RJ, Yaghmai V, Miller F, Ryu RK, Ibrahim S, Sato KT, Kulik LM, Mulcahy MF, Omary R, Murthy R, Reiser MF, Salem R. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90 yttrium microspheres. Dig Dis Sci 53(9):2556-2563, 2008. e-Pub 2008. PMID: 18231857.
46. Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol 31(3):271-279, 2008. PMID: 18525307.
47. Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol 19(5):691-697, 2008. e-Pub 2008. PMID: 18440457.
48. Kamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol 31(2):299-307, 2008. PMID: 17922160.
49. Murthy R, Mutha P, Lee JH, Oh Y. Yttrium-90-labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol 19(2 Pt 1):299-300, 2008. PMID: 18341967.
50. Tam A, Krishnamurthy S, Pillsbury EP, Ensor JE, Gupta S, Murthy R, Ahrar K, Wallace MJ, Hicks ME, Madoff DC. Percutaneous image-guided splenic biopsy in the oncology patient: An audit of 156 consecutive cases. J Vasc Interv Radiol 19(1):80-87, 2008. PMID: 18192471.
51. Tam A, Wagner-Bartak NA, Wallace MJ, Murthy R. Liver abscess after inadvertent transhepatic transgression during percutaneous fluoroscopy-guided gastrostomy. Clin Radiol 63(6):731-735, 2008. e-Pub 2007. PMID: 18455567.
52. Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 15(4):979-985, 2008. e-Pub 2008. PMID: 18236115.
53. Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 19(8):1187-1195, 2008. PMID: 18656012.
54. Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19(5):683-90, 2008. e-Pub 2008. PMID: 18440456.
55. Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Miller F, Yaghmai V, Murthy R, Larson A, Omary RA, Salem R. Multimodality imaging following 90Y radioembolization: A comprehensive review and pictorial essay. Radiographics 28(1):81-99, 2008. PMID: 18203932.
56. Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145-51, 2008. PMID: 18192482.
57. Murthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic Yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18(12):1588-1591, 2007. PMID: 18057297.
58. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC. Transcatheter therapy for hepatic malignancy: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 18(12):1469-1478, 2007. PMID: 18057279.
59. Gupta S, Hicks ME, Wallace MJ, Ahrar K, Madoff DC, Murthy R. Outpatient management of post biopsy pneumothorax with small-caliber chest tubes: Factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol 31(2):342-348. e-Pub 2007. PMID: 18074173.
60. Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-7, 2007. PMID: 18057284.
61. Krishnan S, Briere TM, Dong L, Murthy R, Ng C, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: Screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys 34(12):4591-4593, 2007. PMID: 18196785.
62. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R. Radioembolization with Y90 microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol 30(4):571-592, 2007. e-Pub 2007. PMID: 17516113.
63. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18(4):553-61; quiz 562, 2007. PMID: 17446547.
64. Gupta S, Henningsen JA, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME. Percutaneous biopsy of head and neck lesions with CT guidance: Various approaches and relevant anatomic and technical considerations. Radiographics 27(2):371-390, 2007. PMID: 17374859.
65. Kennedy AS, Warner R, McNeillie P, Dezarnl WA, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Liu D, Overton C, Salem R. Radioembolization for neuroendocrine hepatic metastases. Cancer Investigation 25(1):55-56, 2007.
66. Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: Response, survival, and prognostic factors. Cancer 107(12):2833-2841, 2006. PMID: 17096432.
67. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17(8):1235-1249; quiz 1250, 2006. PMID: 16923972.
68. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412-25, 2006. PMID: 16690429.
69. Madoff DC, Denys A, Wallace MJ, Murthy R, Gupta S, Pillsbury EP, Ahrar K, Bessoud B, Hicks ME. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-211, 2005. PMID: 16227491.
70. Kobayashi K, Murthy R, Madoff DC. Acute endovascular stent-graft occlusion after treatment of an arterio ureteral fistula. J Vasc Interv Radiol 16(10):1409-1410, 2005. PMID: 16221916.
71. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics 25 Suppl 1:S41-55, 2005. PMID: 16227496.
72. Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium-90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol 16(7):937-945, 2005. PMID: 16002501.
73. Gupta S, Seaberg K, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME. Imaging-guided percutaneous biopsy of mediastinal lesions: Different approaches and anatomic considerations. Radiographics 25(3):763-786; discussion 786-788, 2005. PMID: 15888624.
74. Gupta S, Krishnamurthy S, Broemeling LD, Morello FA, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. Small (<2-cm) subpleural pulmonary lesions: Short versus long needle path for computed tomography-guided biopsy of small pulmonary lesions: comparison of diagnostic yield and complications. Radiology 234(2):631-637, 2005. PMID: 15673500.
75. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215-225, 2005. PMID: 15713922.
76. Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 2004. PMID: 15525755.
77. Avritscher R, Madoff DC, Ramirez PT, Wallace MJ, Ahrar K, Morello FA, Gupta S, Murthy R, Wright KC, Hicks ME. Fistulas of the lower urinary tract: Percutaneous approaches for the management of a difficult clinical entity. Radiographics 24(Suppl 1):S217-S236, 2004. PMID: 15486242.
78. Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME. Inferior vena caval filters: Survival in patients with malignancy. Cancer 101(8):1902-1907, 2004. PMID: 15386336.
79. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices. Cardiovasc Intervent Radiol 27(3):259-61, 2004. e-Pub 2004. PMID: 15108022.
80. Gupta S, Nguyen HL, Morello FA, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME. Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions under CT guidance: Anatomic and technical considerations. Radiographics 24(1):175-189, 2004. PMID: 14730045.
81. Rundback JH, Dorfman G, Safriel Y, Mauro M, Wright K, Bonn J, Farahani K, Murthy R. Development of a research agenda for interventional oncology: Proceedings from an interdisciplinary consensus panel. J Vasc Interv Radiol 15(1 Pt 1):7-12, 2004. PMID: 14709681.
82. Gupta S, Madoff DC, Ahrar K, Morello FA, Wallace MJ, Murthy R, Hicks ME. CT-guided needle biopsy of deep pelvic lesions by extraperitoneal approach through iliopsoas muscle. Cardiovasc Intervent Radiol 26(6):534-538, 2003. PMID: 15061177.
83. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: The MD Anderson experience. Cancer J 9(4):261-267, 2003. PMID: 12967136.
84. Safriel Y, Murthy R, Kergosien Y. The ACR-RSNA fellowship in clinical trials of medical imaging: Reflections from the 2002 recipients. Acad Radiol 10(5):565-566, 2003. PMID: 12755547.
85. Sarkodee-Adoo C, Taran I, Guo C, Buadi F, Murthy R, Cox E, Lopez R, Westphal S, Shope S, O'Connell B, Wethers L, Meisenberg B. Influence of pre-apheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Bone Marrow Transplant 31(10):851-855, 2003. PMID: 12748660.
86. Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2):199-203, 2003. PMID: 12607837.
87. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B, Cooper C. Axillary artery traumatic pseudoaneurysm managed with a Wallgraft endoprothesis. J Vasc Interv Radiol 14(1):117-118, 2003. PMID: 12525598.
88. Murthy R, Arbabzadeh M, Lund G, Richard H, Levitin A, Stainken B. Percutaneous transrenal hemodialysis catheter insertion. J Vasc Interv Radiol 13(10):1043-1046, 2002. PMID: 12397127.
89. Murthy R, Wesley BA, Coldwell DM. Totally implanted venous access device removal in interventional radiology. Clin Radiol 57(9):850-852, 2002. PMID: 12384113.
90. Murthy R. New horizons in oncologic embolotherapy. J Vasc Interv Radiol 13(2):P116-P123, 2002.
91. Richard HM, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG, Ostergaard C, Coldwell DM. A randomized, prospective evaluation of the Tesio, Ash split, and Opti-flow hemodialysis catheters. J Vasc Interv Radiol 12(4):431-435, 2001. PMID: 11287528.
92. Richard HM, Coldwell DM, Boyd-Kranis RL, Murthy R, Van Echo DA. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 12(3):373-375, 2001. PMID: 11287517.

Invited Articles

1. Murthy R. Phase 1 Trial of image-guided oncolysis by clostridium novyi-NT spore inoculation: Early technical insights. Journal of Vascular and Interventional Radiology (JVIR), 2015.
2. Murthy R, Kamat P, Nunez R, Salem R. Radioembolization of Yttrium-90 microspheres for hepatic malignancy. Semin Interv Radiol 25(1):48-57, 2008.
3. Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff D. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Interv Radiol 25:132-145, 2008.
4. Salem R, Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Ibrahim S, Nemcek AA, Omary RA, Madoff DC, Murthy R. Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10(1):12-29, 2007. PMID: 17980315.
5. Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolization yttrium-90 microspheres. Biomed Imaging Interv J 2(3):e43:1-10, 2006.
6. Wallace MJ, Murthy R. Transarterial therapy for patients with hepatic malignancy. Semin Interv Radiol 22:316-328, 2005.
7. Murthy R, Hastings GS, Richard HM III, Levitin A. Angiography and endovascular intervention for vascular trauma to the extremities. Semin Interv Radiol 20:81-88, 2003.

Manuals, Teaching Aids, Other Teaching Publications

1. Coldwell D, Murthy R, Nutting C, Salem R. Practice guideline for radioembolization with microsphere brachytherapy device (TMBD) for treatment of liver malignancies: American College of Radiology Guidelines, 2008.
2. Kennedy A, Nag S, Murthy R, Dezarn W, Nutting C, Coldwell D, Salem R, Liu D. Liver-directed radiotherapy using microspheres (radioembolization) for primary and metastatic cancers, 2008.
3. Murthy R, Jakobs T. Spheres of progress in cancer treatment. Merion Publications: King of Prussia, PA, 2007.
4. Murthy R. Radiotherapy with microspheres showcases latest research on microsphere therapy. East Valley Living Articles, 2006.
5. Salem R, Kulik L, Murthy R. Radioembolization with Yttrium-90 microspheres for the treatment of hepatocellular carcinoma and liver metastases: Touch Briefings website - US Gastroenterology Review, 2006.
6. Murthy R. Irradiated microspheres lead to palliative option for unresectable liver cancer, 2001.
7. Murthy R. Emergency Medicine Bulletin Board System, 2000.

Other Articles

1. Janku F, Zhang H, Pezeshki AM, Goel S, Murthy R, Wang-Gillam A, Shepard D, Helgason T, Masters T, Hong D, Piha-Paul S, Karp D, Klang M, Sakamuri D, Raina A, Torrisi J, Solomon S, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom J, Korn R, Zhang L, Saha S, Leontovich A, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder M Intratumoral injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors: Results of a first-in-man dose-escalation study. Cancer Discovery, 2019.
2. Murthy R Early research: Genetically modified bacteria spores injected into solid tumors destroy cancer. Oncology Times 37:25-26, 2015.
3. Gamblin CT, Murthy R Small beads, big hope - Radioembolization with microspheres targets liver cancer. Radiology Today 9(14):26, 2008.

Editorials

1. Murthy R, Szklaruk J.. Invited commentary. Radiographics 25(Suppl 1):S97-S98, Oct, 2005.

Abstracts

1. Kappadath S, Teyateeti A, Abdelsalam M, Avritscher R, Chasen B, Kuban J, Murthy R, Odisio B, Macapinlac H, Mahvash A. Survival outcomes for transarterial 90Y-radioembolization with glass microspheres in advanced hepatocellular carcinoma patients. Journal of Vascular and Interventional Radiology 31(3 Supplement):S244-S245, 2020.
2. Gurusamy V, Odisio B, Kuban J, Abdelsalam M, Avritscher R, Chasen B, Murthy R, Mahvash A. Temporary reversal of hepatoenteric collaterals during Y90 planning and treatment. Journal of Vascular and Interventional Radiology 31(3 Supplement):S245, 2020.
3. Carter BW, Murthy R, Balmes G, Wachter EA, Patel S. Response assessment of metastatic uveal melanoma treated with rose bengal disodium. Annals of Oncology 30(Supplement 11):xi46, 2019. e-Pub 2019.
4. Sheth RA, Murthy. Image-guided intratumoral delivery of immunotherapeutics: Interventional radiology perspective. SITC 33rd Annual Meeting, 2018.
5. Chauhan N, Bukovcan J, Boucher E, Cosgrove D, Edeline J, Hamilton B, Hulik L, Master F, Salem R, Murthy R. Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma: Protocal for the STOP-HCC phase 3 randomized controlled trial. Journal of Medical Internet Research, 2018. e-Pub 2018.
6. Diab A, Murthy R. A phase 2 study to evaluate the safety and efficacy of intratumoral (IT) injection of the TLR9 agonist IMO-2125 (IMO) in combination with ipilimumab (ipi) in PD-1 inhibitor refractory melanoma. 2018 Asco Annual Meeting, 2018.
7. Johnson D, Murthy R. Phase I/II dose escalation and expansion cohort safety and efficacy study of image guided intratumoral CD40 agonistic monoclonal antibody APX005M in combination with systemic pembrolizumab for treatment naive metastatic melanoma. 2018 ASCO Annual Meeting, 2018.
8. Babiker H, Murthy R. Preliminary safety of deep/visceral (D/V) image guided (IG) intratumoral injection (ITI) of IMO-2125. 2018 ASCO Annual Meeting. e-Pub 2018.
9. Murthy R. Immunotherapy trials in interventional oncology. 2018 Cancer Imaging and Intervention Conference (CIIC), 2018.
10. Xu M, Ouyang F, Alshawa A, Hajjar J, Castillo L, Shing G, Le H, Murthy, Naing A, Tapia C R. Tumor burden and lymphocytic infiltrate in on-treatment biopsies is significantly associated with response to pembrolizumab in patients with rare tumors. USCAP's 2018 Annual Meeting, 2018.
11. Murthy R, Hong DS, Prins RM, Hendricks K, Campion S, Hosing C, Brown RE, McGuire M, Naing A, Fu S, Pina-Paul SA, Chawla SP, Sankhala KK, Conley AP, Welsh JW, Kaur I, Noffsinger L, Bosch ML, Subbiah V. Cytokine production by intratumorally administered activated dentritic cells correlates with survival in a Phase 1 clinical trial. ASCO Annual Meeting Collective Wisdom, 2017.
12. Rachakonda V, Bassuner J, Murthy R. Cost effectiveness of percutaneous transhepatic biliary drainage catheters in malignant biliary obstruction: Financial analysis. SIR 2017, 2017.
13. Murthy R, Rachakonda V, Mahvash A, Huang SY, Sabir SH, Subbiah V, Janku F, Kaseb AO, Javie MM, Murth A. Percutaneous transhepatic biliary drainage in hepatopancreaticobiliary cancer: Contemporary efficacy. J Clin Oncol, 2016.
14. Murthy R, Rachakonda V, Mahvash A, Huang SY, Sabir SH, Subbiah V, Janku F, Kaseb AO, Javie MM, Murthy A. Percutaneous transhepatic biliary drainage in hepatopancreaticobiliary cancer: Contemporary efficacy. 2016 ASCO Annual Meeting, 2016.
15. Odisio BC, Cox VL, Mahvash A, Xiao S, Ensor J, Wallace MJ, Jones AK, Gupta S, Tam AL, Murthy R, Faria SC. Incidentally-found miliary liver lesions on Cone-beam CT angiography: Higher risk for metastatic hepatic disease progression. 2016 WCIO, 2016.
16. Janku F, Murthy R, Wang-Gillam AW, Shepard D, Helgason T, Henry T, Rudin C, Huang S, Sakamuri D, Solomon S, Collins A, Kreider B, Miller M, Saha S, Tung D, Varterasian M, Zhang L, Zhang H, Gounder M. Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers. 28 EORTC-NCI-AACR Symposium 2016, 2016.
17. Subbiah V, Murthy R, Hong DS, Prins R, Hosing C, Brown R, McGuire M, Naing A, Fu Siquing, Lin Q, Conley A, Kaur I, Bosch M. Safety, feasibility and activity of intratumoral injection of activated autologous dendritic cells in solid tumors: A phase I clinical trial. AACR 2015 Annual Meeting, 2015.
18. Murthy R, Subbiah S, Mahvash A, Odisio BC, Gupta S, Ahrar J, Sabir Sh, Huang S, Bosch M. Image-guided autologous dendritic cell vaccination in advanced cancer: Technical aspects. 7th Annual Symposium on Clinical Interventional Oncology, 2015.
19. Murthy R, Subbiah V, Mahvash A, Odisio BC, Gupta S, Ahrar J, Bosch Marnix. Phase 1 trial of image-guided vaccination of autologous dendritic cell in advanced cancer: technical aspects. Clinical-Interventional Oncology 2015 Meeting, 2015.
20. Murthy R, Huang S, Thorunn H, Janku F. Phase 1 trial of image-guided oncoloysis by Clostridium novyi-NT spore inoculation: Early technical insights. Clinical-Interventional Oncology 2015 Meeting, 2015.
21. Ahrar J, Ensor J, Mahvash A, Sabir SH, Steele J, McRae S, Avritscher R, Huang S, Odisio BC, Murthy R, Ahrar K, Wallace M, Gupta S. Efficacy of a self-expanding tract sealant device in the reduction of pneumothorax and chest tube placement rates after percutaneous lung biopsy: A matched controlled study using propensity score analysis. SIR 40th Annual Scientific Meeting 2015, 2015.
22. Subbiah V, Brown RE, Prins R, Murthy R, McGuire M, Hosing C, Conley A, Kaur I, Hong DS, Meric-Bernstam F, Bosch M. Immunologic correlates of activity of image guided intra-tumoral vaccination of autologous activated dendritic cells in high grade unresectable sarcoma. Proceedings for the American Association for Cancer Research (AACR) 2014 Meeting In Orlando, Florida, 2014.
23. Subbiah V, Kayaleh O, Murthy R, Hong D, Fu S, Naing A, Conley A, Hosing C, Kaur I, Prins "R, Meric-Berstam F, Bosch M. Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment. The Society for Immunotherapy of Cancer (SITC) - 29th Annual Meeting, National Harbor, MA, 2014.
24. Black B, Jones AK, Mahvash A, Odisio BC, Avritscher R, Ensor J, Murthy R, Steele JR. Temporary balloon occlusion of the common hepatic artery during Y90 radioembolization. SIR 2013 39th Annual Scientific Meeting, San Diego, CA, 2014.
25. Mahvash A, Odisio BC, Avritscher R, Chasen B, Murthy R. Temporary balloon occlusion of the common hepatic artery during Y90 radioembolization planning and treatment in patients with patent hepatoenteric collaterals. Proceedings of the 2014 Society of Interventional Radiology Annual Scientific Meeting 25(3, Supplement):S87-S88, 2014.
26. Subbiah V, Murthy R, Hosing C, Kaur I, Falchook G, Bosch M. DCVax®- direct: Autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - A phase I/II clinical trial in progress. Proceedings of Society of Immunotherapy of Cancer (SITC) 28th Annual Meeting, 2013.
27. Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Acta Radiol 54(7):790 - 794, 2013. e-Pub 2013. PMID: 23535183.
28. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?. World J Radiol 5(6):241-247, 2013. PMID: 23807902.
29. Gadani S, Avritscher R, Odisio BC, Murthy R, Mahvash A.. Infectious complications of Y90 radioembolization in patients with surgical bilioenteric anastamosis or compromised sphincter of oddi: The md anderson experience. The World Conference of Interventional Oncology Annual Meeting, 2013.
30. Gadani S, Mahvash A, Avritscher R, Chasen B, Kaseb A, Murthy R. Yttirum-90 resin microspheres as an adjunct to sorafenib in patients with unresectable HCC: A retrospective study for evaluation of survival benefit and adverse events. JVIR (Supplement) 24(4):S35, 2013.
31. Shreyaah S, Odisio BC, Garrett C, Avritscher R, Murthy R. KRAS mutant metastatic colorectal cancer; Is there a role for Yttrium-90 microsphere radioembolotherapy. JVIR (Supplement) 24(4):S112 - S113, 2013.
32. Odisio BC, Shreyaah S, Mahvash A, Avritscher R, Chasen B, Murthy R, Garrett C.. KRAS mutant metastatic colorectal cancer: Is there a role for Yttrium-90 microsphere radioembolotherapy. 38th Annual Meeting of the Society of Interventional Radiology, 2013.
33. Overman MJ, Modak J, Kopetz S, Murthy R, Yao JC, Hicks ME, Abbruzzese JL, Tam AL. Use of research biopsies in clinical trials: Are risks and benefits adequately discussed?. J Clin Oncol 31(1):17-22, 2013. e-Pub 2012. PMID: 23129736.
34. Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol:560758, 2013. e-Pub 2013. PMID: 23710405.
35. Mahvash A, Murthy R. Yttrium - 90 microsphere radioembolotherapy for adolescent hepatic malignancies: Early experience at MD Anderson Cancer Center. Proceedings of the 5th Pediatric Interventional Radiology Symposium at the Hospital for Sick Children, Toronto, 2012.
36. Maclellan C, Hobbs BP, Chasen B, Murthy R, Mahvash A, Kappadath SC. Absorbed dose differences in 90Y microsphere therapy between pre-treatment 99m Tc-MAA and post-treatment 90Y scans. J Nuclear Medicine(53(Supplement 1)):323, 2012.
37. Mahvash A, Moayyad J, Shreyaah S, Avritscher R, Murthy R. Y90 radioembolization in patients with compromise of the ampulla of vater. GEST 2012 U.S. Abstracts - JVIR:577.e12, 2012.
38. Enriquez J, Javadi S, Ensor J, Murthy R, Mahvash A, Abdelsalam M, Madoff D, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. GEST 2012 U.S. Abstracts - JVIR:577.e4, 2012.
39. Mahvash A, Shreyaah S, Chasen B, Avritscher R, Murthy R. Balloon-catheter occlusion technique for administration of Y90 microspheres in patients with patent hepatoenteric arteries. J Vasc Interv Radiol Supplement 23(3S):S67 - S68, 2012.
40. McCann J, Larkin A, Moore L, Johnson M, Sze D, Kwofie J, Saad N, Parikh P, Murthy R, Erin W, Kolbeck K, Franco J, Brown D. Multi-center correlation of external exposure rates from 90Y radioembolization patients: Contact precautions are unnecessary based on Nuclear Regulatory Commission regulations. J Vasc Interv Radiol Supplement 23(3S):S68 - S69, 2012.
41. Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam AL, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae SE, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: A large single-center study. J Vasc Interv Radiol Supplement 23(3S):S27 - S28, 2012.
42. Speer M, Abdelsalam M, Chasen B, Murthy R, Mahvash A, Avritscher R. The retroportal artery and other less well-known hepatoenteric pathways: Moving beyond GDA and right gastric embolization. J Vasc Interv Radiol Supplement 23(3S):S151, 2012.
43. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Imaging pattern of neuroendocrine tumor hepatic metastases as a predictor of response to yttrium-90 radioembolotherapy. WCIO 2011 Annual Conference, 2011.
44. Murthy R, Mahvash A, Phan A, James Y, Wallace MJ. Y90 resin microsphere arterial redioembolotherapy as a therapeudic adjunct to systemic biologic therapy for advanced hepatic metastic neuroendocrine tumor progression. Proceedings of World Conference on Interventional Radiology, 2011.
45. Subbiah V, Murthy R Anderson PM. [90Y]Yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29(11):e292-e294, 2011. e-Pub 2011. PMID: 21245431.
46. Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 2011. PMID: 21166498.
47. Murthy R, Wallace M, Madoff DC, Avritscher R, Mahvash A. Quantification of hepatopulmonary shunting using C-Arm CT: Potential implications for Y90 microsphere radioembolotherapy program. Proceedings of the World Conference on Interventional Oncology 2010 Annual Meeting, 2010.
48. Murthy R, Mahvash R, Avritscher, Erwin W, Chasen B., Eng C. Yttrium microspheres with cituximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. J Clin Oncol 28(15s):TPS197, 2010. e-Pub 2009.
49. Avritscher R, Wright KC, Gagea-Iurascu M, Murthy R, Madoff M. Development of a large animal model for liver cirrhosis. Proceedings of the 35th Annual Scientific Meeting of The Society of Interventional Radiology 21(2S):S76, 2010.
50. Briere TM, Beddar S, Balter P, Murthy R, Gupta S, Nelson C, Starkschall G, Gillin MT, Krishnan S. Respiratory gating with EPID-based verification: The MDACC experience. Phys Med Biol 54(11):3379-3391, 2009. e-Pub 2009. PMID: 19436104.
51. Mutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Extrahepatic progression of hepatic-only colorectal cancer: Impact on combinatorial (systemic + local therapy) clinical trial design. Proceedings of the 34th Annual Meeting of Society of Interventional Radiology 20(2S):S63, 2009.
52. Mutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Patterns of disease progression of colorectal cancer: A systematic review of the MD Anderson Cancer Center Tumor Registry. Proceedings of the 4th Interventional Symposium on Regional Cancer Therapies Conference, 2009.
53. Gupta S, Wallace M, Ahrar K, Madoff D, Murthy R, Hicks M, Suitor C, McEnery K, Patel J. Integration of online reporting system for interventional radiology procedure-related complications with the digital dictation system: Early experience. J Vasc Interv Radiol 20(2):S41-S42, 2009.
54. Kappadath S, Erwin W, Mutha P, Prasad S, Murthy R. Comparison of three radiation dosimetry models for yttrium-90 microsphere. Proceedings of the Society of Nuclear Medicine Annual Meeting, 2009.
55. Murthy R, Mutha P, Lee JH, Oh Y. Yttrium-90 labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol 19(2)(2 Pt 1):299-302, 2008. PMID: 18341967.
56. Madoff DC, Abdalla EK, Wallace MJ, Murthy R, Ahrar K, Gupta S, Wei SH, Hicks ME, Vauthey JN. Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for patients with hepatocellular carcinoma. Cardiovasc Interv Radiol 29(Suppl 1)(S202), 2008.
57. Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145-151, 2008. PMID: 18192482.
58. Clyde S, Wei A, Murthy R. Is the inability to achieve procedure related pain control influenced by pre-procedure narcotic use?. J Vasc Interv Radiol 19(2):S34, 2008.
59. Mutha P, Murthy R. Can percutaneous hepatic artery infusional chemotherapy procedures be safely performed with concomitant systemic bevacizumab therapy?. Proceedings of the Third International Symposium on Regional Cancer Therapies Annual Meeting, 2008.
60. Gayed I, Murthy R. Treatment of multiple liver metastases with Y-90 SIR spheres: The experience of a large cancer center (Therapy, Metrics & Intervention Posters). Proceedings of the Society of Nuclear Medicine Annual Meeting, 2008.
61. Avritscher R, Madoff D, Murthy R, Mahvash A, Wallace M. Adjunctive use of c-arm cone-beam ct during percutaneous gastrostomy insertion may help increase safety and technical success rate in patients with difficult access. Proceedings of the Radiological Society of North America Annual Meeting, 2008.
62. Mutha P, Macapinlac H, Kamat P, Madoff DC, Gupta S, Ahrar K, Wallace M, Murthy R. Continued role of Tc 99m MAA scintigraphic detection of extrahepatic perfusion prior to initiating percutaneous trans-catheter hepatic artery chemotherapy. AJR Am J Roentgenol 190(4 Supplement, A52), 2008.
63. Mutha P, Madoff DC, Gupta S, Avritscher R, Murthy R. Hepatic metastatic colorectal cancer patients with advanced disease appear to exhibit poor response rates to Y90 hepatic radioembolotherapy. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium, 2008.
64. Verma R, Singh S P, Murthy R, Kundra V. In vitro activation of radiation sensitive promoter (Egr-1) via radiation from Y-90 microspheres. J Vasc Interv Radiol 19(2):S47, 2008.
65. Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-Arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-1507, 2007. PMID: 18057284.
66. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13-23, 2007. PMID: 17448867.
67. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18(4):553-561, 2007. PMID: 17446547.
68. Kamat PP, Camacho L, Madoff DC, Gupta S, Murthy R. Gastrointestinal toxicity associated with hepatic artery infusional chemotherapy is not prevented by the exclusion of extrahepatic perfusion as demonstrated by pre-therapy arteriography and nuclear scintigraphy. Proceedings of the Radiological Society of North America Scientific Assembly and Annual Meeting Program:293, 2007.
69. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412-425, 2006. PMID: 16690429.
70. Murthy R, Oh Y, Tam A, Gupta S, Madoff DC, Glisson B. Yttrium-90 microsphere treatment for liver dominant hepatic metastases from lung cancer. J Clin Oncol 24(18s):17122, 2006.
71. Murthy R, Xiong H, Eng C, Habbu A, Canet S, Hicks M. Yttrium-90 microsphere liver directed therapy in patients with metastatic colorectal cancer following failure of cetuximab and bevacizumab. Proceedings of the World Conference on Interventional Oncology, Annual Meeting, 2006.
72. Murthy R, Habbu A, Richey S, Eng C. Implications of patterns of metastases of mCRC on liver directed therapy in patients undergoing combination systemic treatment with irinotecan and cetuximab. Proceedings of the World Conference on Interventional Oncology, Annual Meeting, 2006.
73. Kobayashi K, Gupta S, Trent J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization in patients with metastatic gastrointestinal stromal tumors refractory to imatinib. J Vasc Interv Radiol 17:S77-S78, 2006.
74. Morello FA Jr, Rao SH, Harle MT, Mobley GM, Murthy R, Cleeland C. Pain quantification and patient satisfaction in interventional radiology. Proceedings of the 2005 Society of Interventional Radiology 30th Annual Scientific Meeting, 2005.
75. Murthy R, Gupta S, Madoff D, Nunez R, Yao J, Szklaruk J. Feasibility of hepatic arterial therapy with Yttrium-90 microspheres, SIR-Spheres, in metastatic neuroendocrine neoplasia with hepatic dominant progression after failure of multiple systematic and hepatic artery therapies. Proceeding of the Radiological Society of North America (RSNA) Annual Meeting. e-Pub 2005.
76. Madoff DC, Abdalla E, Gupta S, Tsung-Teh W, Morris JS, Denys a, Wallace M, Morello F, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey N,. Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 (Pt1)):215-25, 2005. PMID: 15713922.
77. Gupta S, Johnson MM, Murthy R, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: Variables affecting response rates and survival. Cancer 104(8):1590-1602, 2005. PMID: 16134179.
78. Murthy R, Nunez R, Szklaruk F, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace M, Cohen A, Coldwell D, Kennedy A, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41-55, 2005. PMID: 16227496.
79. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices. Cardiovasc Intervent Radiol 27(3):259-261, 2004. e-Pub 2004. PMID: 15108022.
80. Madoff DC, Wallace MJ, Murthy R, Gupta S. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-211, 2004. PMID: 16227491.
81. Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2):199-203, 2003. PMID: 12607837.
82. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: The M.D. Anderson experience. Cancer J 9(4):261-7, 2003. PMID: 12967136.
83. Murthy R, Kennedy AS, Coldwell DM, Lund G, Stainken BF, Van Echo DA. Technical aspects of TheraSphere (TS) infusion (MDS Nordion, Kanata, Canada). Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
84. Murthy R, Kennedy AS, Coldwell DM, Lund G, Stainken BF, Van Echo DA. Trans-arterial brachytherapy for hepatic malignancies utilizing particle emitting yttrium-90 microspheres. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
85. Murthy R, Kennedy AS, Line BR, Lund GB, Stainken B, Van Echo DA, et al. Augmentation of hepatopulmonary shunting following trans-arterial hepatic brachytherapy (TAHB) with Yttrium-90 25µm spheres: TheraSphere® -therapeutic implications. Proceedings of the 88th Annual Meeting of the Radiological Society of North America 225:307, 2002.
86. Murthy R, Line B, Kennedy AS, Stainken BF, Mourtzikos K, Van Echo DA. Clinical utility of Brehmstralung scan (BRM-scan) after TheraSphere (TS) (MDS Nordion, Kanata, Canada) administration. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
87. Kennedy AS, Murthy R, Safaraz M, Yu C, Ma L, Van Echo D. Outpatient (MDS Nordion, Canada) administration. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2002.
88. Van Echo DA, Kennedy AM, Coldwell DM, Murthy R, Sarfaraz M, Line B. TheraSphere (TS) for mixed hepatic cancers at 143 Gy median dose, feasibility and toxicities. Proceedings of the American Society of Clinical Oncology, 2001.
89. Murthy R, Kennedy AS, Tucker G, Murthy A, Van Echo D. Outpatient trans arterial hepatic low dose rate brachytherapy for unresectable hepatocellular carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting, 2001.
90. Murthy R, Sarkodee-Adoo C, Scholfield K. Lowering patient transfusion threshold requirements for tunneled central venous catheter (TCVC) insertion: Interim results. Proceedings of the American Society of Hematology Annual Meeting, 2001.
91. Coldwell DM, Van Echo D, Kennedy A, Murthy R, Boyd-Dranis R, Hastings G. Feasibility of treatment of hepatic tumors utilizing embolization with yttrium-90 glass microspheres. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2001.
92. Coldwell DM, Van Echo D, Murthy R, Boyd-Kranis R, Hastings GS, Radack D. Treatment of radio-resistant head and neck squamous cell carcinomas (HNSCC) with super selective intra-arterial infusion of platinol. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2001.
93. Kennedy AS, Murthy R, Kwok Y, Tucker G, Kanani S, K Desai BS, Van Echo DA. TheraSphere for hepatocellular carcinoma. Proceedings of the International Conference on Cancer Therapy Annual Meeting, 2001.
94. Murthy R, Schofield K, Wesley B, Bouchelle Z, Lloyd P, Richard HM III. Safety & feasibility of ultrasound & fluoroscopic assisted PICC line insertion (UFPI) by a team of nurse's functioning under the aegis of interventional radiology (IR). Proceedings of the Radiological Society of North America Annual Meeting, 2001.
95. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack D, Santilli JG. Feasibility of trapease inferior vena cava (IVC) filter insertion using single venous puncture and intravascular ultrasound (IVUS) guidance. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiology Society of Europe, 2001.
96. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack DM, Stainken BF. Hepatic vein hemodynamic assessment predicts pathological finding at transjugular liver biopsy. Proceedings of the Annual meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 2001.
97. Kennedy A, Murthy R, Van Echo D. Preliminary results of outpatient hepatic artery brachytherapy for colorectal hepatic metastases. Proceedings of the European Conference on Clinical Oncology Annual Meeting, 2001.
98. Boyd-Kranis RL, Hastings GS, Coldwell DM, Murthy R, Santilli JG, Radack D. Blunt splenic injury: The use of angiography and embolization for nonoperative treatment. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2000.
99. Richard HM III, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG. A randomized prospective evaluation of the Tesio, Ash split and Bard Optiflow hemodialysis catheters. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2000.
100. Richard HM III, Coldwell DM, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM. Pleurx tunneled catheter in the management of malignant ascites. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting 12(3):373-5, 2000.
101. Grigorev I, O'Connell B, Cottler-Fox M, Murthy R, Chen T, Meisenberg B, Sarkodee-Adoo C. Factors affecting the efficiency of stem cell collection by apheresis: A multivariate analysis. Proceedings of the American Society of Hematology Annual Meeting, 2000.
102. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack D, Santilli JG. Tunneled central venous catheter insertion in patients with thrombocytopenia. Proceedings of the Society of Vascular Medicine and Biology Annual Meeting, 2000.
103. Hastings GS, O'Connor D, Boyd-Kranis RL, Murthy R, Pais SO, Coldwell DM. Bleeding complications of translumbar hemodialysis catheter insertion. Proceedings of the American Roentgen Ray Society Annual Meeting, 1999.
104. Hastings GS, Boyd-Kranis RL, Murthy R, Santilli JG, Pais SO, Coldwell DM. Compulsory use of Site-Rite sonographic guidance for low internal jugular vein access eliminates major puncture-related complications. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 1999.
105. Hastings G, Markert D, Boyd-Kranis R, Murthy R, Pais O, Coldwell D. Rotational angiography in trauma. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 1999.
106. Hastings GS, Santilli JG, Boyd-Kranis RL, Murthy R, Pais SO, Coldwell DM. Lace and go thrombolysis for dialysis grafts. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 1999.

Book Chapters

1. Odisio BC, Murthy R. Image-guided therapies for hepatocellular carcinoma. In: Hepatocellular carcinoma - future outlook. InTech - Open Access Publisher, 2013.
2. Murthy R, Mutha P, Gupta S. Yttrium 90 radioembolotherapy for hepatocellular cancer. In: Hepatocellular Carcinoma. Springer Science Business Media, LLC: Totowa, New Jersey, 2010.
3. Murthy R. Contribution - Radioembolization for hepatocellular cancer. In: Hepatocellular Carcinoma: a multidisciplinary approach. Springer, 2009.

Books (edited and written)

1. Kee ST, Madoff DC, Murthy R. Clinical Interventional Oncology. Elsivier, 2013.

Letters to the Editor

1. Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W. Establishment of the radiation effect of yttrium-90 microspheres: role of C-Arm CT. J Vasc Interv Radiol 20: 422-424, 2009.
2. Murthy R, Kamat P, Staerkel G. Podagra. Internet Journal of Radiology 6(1), 2007.
3. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund GA, Stainken B, Cooper C. Axillary artery traumatic pseudoaneurysm managed with a Wallgraft endoprosthesis. J Vasc Interv Radiol 14: 117-118, 2003.